Member Info for EarlofAim

Nice rise this week

Glaw
research and come to your own conclusion, as my conclusion says this DoseMe RX will be mega, because at the moment cancer treatment needs optimisation, and after looking at the Dosage challenges, this looks to have solved all the problem.

example, say you have a brand new car and it runs on petrol, without the petrol this car won't run. similarly 'Docetaxel' is is a good drug to treat various cancers, however if the dosage are not accurate as the cancer is, then the treatment doesn't work as it should do.

how many people survived cancer and how many died by using the same drug? 30 it got to be the individual dosage issue because of the extent of the cancer.

hope this makes sense
GLA

DoseMe RX has the potential to solve the undedose and overdose issues faced by cancer treatment by the this drug 'Docetaxel'
which is used for Chemotherapy to treat number of cancer including Prostate cancer breast cancer, head, cancer, neck cancer stomach cancer and lung cancer.

the question is, how much is @Physiomics going to get for this?

I would say £100m - £250M

worth looking at this tweet from #PYC and try to understand what the company is doing

"When it comes to advanced #prostatecancer, the first line of treatment is often docetaxel, however both 'underdosing' and 'overdosing' remain a challenge. Learn how our precision dosing tool is designed to tackle this: https://t.co/tIeQAaIwqU #PYC https://t.co/fuwnxWf9Ea

some good research on here.

DoseMe RX will be massive in the world of Cancer treatment.

and PYC are the main player in this.
Billions spent in cancer treatment around the world, yet very few survive. Could this be because of the Dose issue?

I mean drugs are available in abundance for cancer treatment however Reading from PYC company website, I think the dosing is the the issue why treatments not responding as it should be.

massive project worldwide application.
Mcap of £6M will become £200m easy when the big pharmaceutical company wake up to this breakthrough technology.

GLA

I never read an So down beat Rns, keeps reiterating "nothing for immediate future" 24 months this is what they're saying, Comon who is willing to wait 24 month and then Huge cash needed.
I would say This is not an investment for right now,
let's wait until they have some clear indication.

this RNS is like saying "don't blame us if we so nothing in the next 12 months, because we did mentioned it in the Rns"

shame to release a Rns with this sort of Rhetoric

the way I see this DoseMe RX, is that no matter how wonderful drug you have for Prostate cancer If the dose is either side of high or less then the medication doesn't work to it's best condition as set out to be.
So as I understand DoseMe is the Game changer for Drugs that are needed to cancer patients.

is this exclusive to Prostate Cancer or this DoseMe RX is applicable to other cancer medication like Liver, breast, etc?

is this is the case, Ben is old Bankrupt company, rebranded!

looks like From top to bottom this was pumped to new investors, that's morally wrong and should get their Karma they deserve.
However if the new Management done this will good intentions without any wrong doing then it's fair play.

watching how this pans out

Mcap of #pyc is covered by #val £6M payment to pyc.

Physiomics partner @valirxplc announced a non-binding agreement with @TheoremRX to sub-license VAL201 for development in the treatment of #cancer

When it comes to advanced #prostatecancer, the first line of treatment is often docetaxel, however both 'underdosing' and 'overdosing' remain a challenge. Learn how our precision dosing tool is designed to tackle this: https://t.co/tIeQAaIwqU #PYC https://t.co/fuwnxWf9Ea

prostate cancer dosing has to be accurate for it to work properly.

some decent research from guys on this Bb.
very good information about the potential of PYC.
GLA and see what happens here in the near future.

wow!!!

https://twitter.com/riddler_smitb/status/1455899721113997323?t=xFB0YiGaa2viG2H5P0YvoA&s=19

PYC precision dosing app is being integrated as we speak with an Update due before year end as confirmed by Dr Jim Millen in his recent presentation to investors.

DoseMeRX has also been integrated into ILUM HEALTH SOLUTIONS - MERCK - Market Cap £207 Billion

DoseMeRX has also been integrated into Wolters Kluwer - Market Cao £24 Billion

DoseMeRX currently being used by Portugals Health Service

DoseMeRx both trails looking posistive - NHS usage next ?

This alone is a HUGE HUGE transformation piece of NEWs which the Market hasn't picked up on - Not only will this generate significant amount of Revenue from Global usage but this will become PYC biggest Assets and will be worth Multi Millions in its own right.

£6m to come from #Val
current PYC mcap £6M

this is a bargain share, Don't know how it stayed flat since yesterday Val Rns

£6m toy come from #Val
current PYC mcap £6M

this is a bargain share, Don't know how it stayed flat since yesterday Val Rns

£400M for NXP004 potentially

mcap £8M, and worth news is said to be later in the year and that was back in June.

news anyday as per Rns, Straight to 60p if the Suggestion is correct.

GLA and Dyor this could make some holders millionaires!!!

so much hate for this company is unbelievable.

kaneonaim

you posted 60p would bring you £3M, which means you invested a good sum of money.

60p would also make many millionaires on Here.

let the news come Soon.
GLA